Standout Papers
- Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer (2019)
- Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial (2016)
- First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer☆ (2021)
- Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up (2023)
Immediate Impact
1 by Nobel laureates 13 from Science/Nature 73 standout
Citing Papers
Pancreatic cancer
2025 Standout
Dendritic cell maturation in cancer
2025 Standout
Works of Talia Golan being referenced
Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer
2019 Standout
Preliminary results of the first-in-human (FIH) study of MK-1454, an agonist of stimulator of interferon genes (STING), as monotherapy or in combination with pembrolizumab (pembro) in patients with advanced solid tumors or lymphomas
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Talia Golan | 5148 | 2235 | 1607 | 1965 | 168 | 6.9k | |
| Shumei Kato | 4363 | 2471 | 2370 | 2072 | 170 | 7.1k | |
| E. Gabriela Chiorean | 4541 | 1632 | 1487 | 2094 | 203 | 6.9k | |
| Alessandro Lugli | 5939 | 1421 | 1685 | 2505 | 210 | 9.5k | |
| Teresa Macarulla | 6176 | 2263 | 2135 | 2835 | 307 | 8.4k | |
| Michael J. Pishvaian | 3666 | 1447 | 1095 | 1907 | 211 | 5.6k | |
| Christophe Rosty | 4324 | 1619 | 1331 | 2615 | 132 | 7.1k | |
| Allen Lee Cohn | 4629 | 1220 | 2314 | 1500 | 158 | 6.7k | |
| Tae‐You Kim | 3193 | 1723 | 2341 | 3081 | 150 | 7.4k | |
| Gunhild Mechtersheimer | 2418 | 888 | 2335 | 1784 | 191 | 6.5k | |
| Takeshi Kuwata | 2847 | 884 | 1760 | 1878 | 191 | 5.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...